Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Buy
56
INNV Quote, Financials, Valuation and Earnings
Last price:
$9.53
Seasonality move
:
0.5%
Day range:
$9.10 - $10.69
52-week range:
$2.60 - $10.69
Dividend yield:
0%
P/E ratio:
227.96x
P/S ratio:
1.57x
P/B ratio:
5.60x
Volume:
748.2K
Avg. volume:
363K
1-year change:
220.24%
Market cap:
$1.4B
Revenue:
$853.7M
EPS (TTM):
$0.05
Earnings Data
Next earnings date for INNV
May 05
2026
Most recent earnings per share
$0.08
Beat by $0.04
(Feb 3/2026)
Consensus Estimate
$0.04
(Feb 3/2026)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
INNV Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 05/05/2026 | Q1 | $234.3M | -- | -- | $0.05 | -- |
| 02/03/2026 | Q4 | $228.3M | $239.7M | $0.08 | $0.04 | $0.04 |
| 11/04/2025 | Q3 | $226.9M | $236.1M | $0.06 | $0.04 | $0.02 |
| 09/09/2025 | Q2 | $219.8M | $221.4M | -$0.01 | $0.01 | -$0.02 |
| 05/06/2025 | Q1 | $214.1M | $218.1M | -$0.08 | -- | -- |
| 02/04/2025 | Q4 | $210.2M | $209M | -$0.10 | -- | -- |
| 11/05/2024 | Q3 | $203.4M | $205.1M | -$0.04 | -$0.01 | -$0.03 |
| 09/10/2024 | Q2 | $191.5M | $199.4M | -$0.01 | -- | -- |
| 05/07/2024 | Q1 | $188.2M | $193.1M | -$0.04 | -- | -- |
| 02/06/2024 | Q4 | -- | $188.9M | -$0.03 | -- | -- |
| 11/07/2023 | Q3 | -- | $182.5M | -$0.08 | -- | -- |
| 06/30/2023 | Q2 | -- | $176.9M | -$0.08 | -- | -- |
| 03/31/2023 | Q1 | -- | $172.5M | -$0.05 | -- | -- |
| 12/31/2022 | Q4 | -- | $167.5M | -$0.07 | -- | -- |
| 09/30/2022 | Q3 | -- | $171.2M | -$0.10 | -- | -- |
| 06/30/2022 | Q2 | -- | $172.9M | -$0.09 | -- | -- |
| 03/31/2022 | Q1 | -- | $177.4M | -$0.02 | -- | -- |
| 12/31/2021 | Q4 | -- | $175.4M | $0.01 | -- | -- |
| 09/30/2021 | Q3 | -- | $173.1M | $0.06 | -- | -- |
| 06/30/2021 | Q2 | -- | $171.6M | $0.05 | -- | -- |
| 03/31/2021 | Q1 | -- | $156.3M | -$0.08 | -- | -- |
| 12/31/2020 | Q4 | -- | $157.3M | $0.07 | -- | -- |
| 09/30/2020 | Q3 | -- | $152.6M | -$0.37 | -- | -- |
| 06/30/2020 | Q2 | -- | $152.5M | $0.09 | -- | -- |
| 03/31/2020 | Q1 | -- | $144.8M | $0.06 | -- | -- |
| 12/31/2019 | Q4 | -- | $137.3M | $0.00 | -- | -- |
| 09/30/2019 | Q3 | -- | $132.6M | $0.04 | -- | -- |
| 06/30/2019 | Q2 | -- | $130.7M | $0.03 | -- | -- |
| 03/31/2019 | Q1 | -- | $122.5M | $0.05 | -- | -- |
| 12/31/2018 | Q4 | -- | $116.4M | $0.03 | -- | -- |
InnovAge Holding Corp. Earnings Questions
-
How Much did InnovAge Holding Corp. Generate in Revenue Last Quarter?
InnovAge Holding Corp. reported $239.7M worth of top line sales in its most recent quarter.
-
Did InnovAge Holding Corp. Beat Earnings Last Quarter?
InnovAge Holding Corp. announced earnings per share of $0.08 which represents a beat of analyst forecast a $0.04 per share.
-
Is InnovAge Holding Corp. Profitable?
InnovAge Holding Corp. reported $47.9M that represents $0.35 per share over the last quarter.
-
What is the Analyst Consensus for InnovAge Holding Corp. EPS Next Year?
InnovAge Holding Corp.'s earnings are forecast to grow from -$0.22 per share to $0.03 per share next year representing an increase of --.
-
When is InnovAge Holding Corp.'s Earnings Date?
InnovAge Holding Corp.'s next earnings date is May 5, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
49
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 37x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
42
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Buy
93
NBTX alert for Mar 5
Nanobiotix SA [NBTX] is down 6.21% over the past day.
Sell
45
MRNA alert for Mar 5
Moderna, Inc. [MRNA] is down 6.9% over the past day.
Buy
77
SSRM alert for Mar 5
SSR Mining, Inc. [SSRM] is down 7.94% over the past day.
